| Pharmacotherapy for non-alcoholic fatty liver disease: emerging targets and drug candidates VA Prikhodko, NN Bezborodkina, SV Okovityi Biomedicines 10 (2), 274, 2022 | 34 | 2022 |
| Potential drug candidates to treat TRPC6 channel deficiencies in the pathophysiology of Alzheimer’s disease and brain ischemia V Prikhodko, D Chernyuk, Y Sysoev, N Zernov, S Okovityi, E Popugaeva Cells 9 (11), 2351, 2020 | 20 | 2020 |
| Molecular mechanisms for hypoxia development and adaptation to it. Part I VA Prikhodko, NO Selizarova, SV Okovityi Arkhiv patologii 83 (3), 52-61, 2021 | 15 | 2021 |
| Effects of alpha-2 adrenergic agonist mafedine on brain electrical activity in rats after traumatic brain injury YI Sysoev, VA Prikhodko, RT Chernyakov, RD Idiyatullin, PE Musienko, ... Brain Sciences 11 (8), 981, 2021 | 14 | 2021 |
| Molecular mechanisms of hypoxia and adaptation to it. Part II VA Prikhodko, NO Selizarova, SV Okovityi Arkhiv patologii 83 (3), 62-69, 2021 | 12 | 2021 |
| Biological activity of Hypericum perforatum L.(Hypericaceae): a review AL Budantsev, VA Prikhodko, IV Varganova, SV Okovityi Pharmacy & Pharmacology 9 (1), 17-31, 2021 | 11 | 2021 |
| Use of Naïve Bayes Classifier to Assess the Effects of Antipsychotic Agents on Brain Electrical Activity Parameters in Rats YI Sysoev, DD Shits, MM Puchik, VA Prikhodko, RD Idiyatullin, ... Journal of Evolutionary Biochemistry and Physiology 58 (4), 1130-1141, 2022 | 8 | 2022 |
| Automatic analysis of the" Morris Water Maze" behavioral test data DP Chernyuk, AG Zorin, KZ Derevtsova, EV Efimova, VA Prikhodko, ... Zhurnal Vysshei Nervnoi Deyatelnosti Imeni IP Pavlova 71 (1), 126-135, 2021 | 6 | 2021 |
| Effects of empagliflozin and L-ornithine L-aspartate on behavior, cognitive functions, and physical performance in mice with experimentally induced steatohepatitis VA Prikhodko, MA Poveryaeva, AV Bunyat, VE Karev, DY Ivkin, ... Bulletin of Russian State Medical University, 49-57, 2020 | 6 | 2020 |
| A method for chronic registration of brain cortical electrical activity in rats YI Sysoev, VA Prikhodko, RD Idiyatullin, RT Chernyakov, VE Karev, ... Journal of Evolutionary Biochemistry and Physiology 58 (1), 292-301, 2022 | 5 | 2022 |
| Morpholine derivatives as potential agents for neurological manifestations of nervous system diseases VA Prikhodko, YI Sysoev, SV Okovityi Pharmacy Formulas 2 (1), 16-35, 2020 | 5 | 2020 |
| Understanding the complex interplay of persistent and antipersistent regimes in animal movement trajectories as a prominent characteristic of their behavioral pattern profiles … MI Bogachev, AI Lyanova, AM Sinitca, SA Pyko, NS Pyko, AV Kuzmenko, ... Biomedical signal processing and control 81, 104409, 2023 | 3 | 2023 |
| Novel Chromone-Containing Allylmorpholines Induce Anxiolytic-like and Sedative Effects in Adult Zebrafish VA Prikhodko, YI Sysoev, EV Gerasimova, SV Okovityi Biomedicines 10 (11), 2783, 2022 | 2 | 2022 |
| Changes in Brain Electrical Activity after Transient Middle Cerebral Artery Occlusion in Rats YI Sysoev, VA Prikhodko, AV Kan, IA Titovich, VE Karev, SV Okovityi Neurology International 14 (3), 547-560, 2022 | 2 | 2022 |
| Effects of promethazine on the amplitude and spectral characteristics of electrocorticograms in rats DD Shits, MM Puchik, VA Prikhodko, SV Okovityi Вестник Пермского университета. Серия: Биология, 352-356, 2022 | 2 | 2022 |
| Evaluation of the neuroprotective activity of a new allylmorpholine derivative in a rat model of traumatic brain injury VA Prikhodko, AV Kan, YI Sysoev, IA Titovich, NA Anisimova, S v Okovityi Drug development & registration 10 (4), 179-187, 2021 | 2 | 2021 |
| Pharmacokinetics of Intravenously and Intraperitoneally Administered Mafedine Sodium in Mice YI Sysoev, AK Whaley, VA Prikhodko, ED Semivelichenko, EI Eletskaya, ... Pharmaceutical Chemistry Journal 54, 1193-1197, 2021 | 2 | 2021 |
| A Simple Algorithm for Semiquantitative Analysis of Scored Histology Data in the R Environment, on the Example of Murine Non-Alcoholic Steatohepatitis Pharmacotherapy VA Prikhodko, VE Karev, YI Sysoev, DY Ivkin, SV Okovityi Livers 2 (4), 412-424, 2022 | 1 | 2022 |
| Neuropsychiatric disorders of non-alcoholic fatty liver disease VA Prikhodko, SV Okovity Therapy 8 (7), 64-77, 2022 | 1 | 2022 |
| Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review NV Bakulina, SV Tikhonov, SV Okovityi, EA Lutaenko, AO Bolshakov, ... Terapevticheskii arkhiv 94 (12), 1431-1437, 2022 | 1 | 2022 |
Сергей Владимирович ОковитыйСПХФУ, кафедра фармакологии и клинической фармакологииVerified email at pharminnotech.com
